WavoDyne Therapeutics

A new drug class developed with $25 mm of NIH funding to treat cognitive impairment associated with a variety of neurodegenerative diseases.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Rochester, NY, US
  • Currency USD
  • Founded February 2015
  • Employees 2
  • Website wavodyne,com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free